ArticleJournal of cheminformatics2015
A multi-label approach to target prediction taking ligand promiscuity into account.
Article in Journal of cheminformatics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- Advanced Artificial Intelligence Technologies Transforming Contemporary Pharmaceutical Research.Bioengineering (Basel, Switzerland) · 2025Review
- Artificial Intelligence in Pharmaceutical Technology and Drug Delivery Design.Pharmaceutics · 2023Review
- Enhancing reaction-based de novo design using a multi-label reaction class recommender.Journal of computer-aided molecular design · 2020Article
- STarFish: A Stacked Ensemble Target Fishing Approach and its Application to Natural Products.Journal of chemical information and modeling · 2019Article
- Implicit-descriptor ligand-based virtual screening by means of collaborative filtering.Journal of cheminformatics · 2018Article
- DPubChem: a web tool for QSAR modeling and high-throughput virtual screening.Scientific reports · 2018Article
- How to Achieve Better Results Using PASS-Based Virtual Screening: Case Study for Kinase Inhibitors.Frontiers in chemistry · 2018Article
- Evidence-Based Precision Oncology with the Cancer Targetome.Trends in pharmacological sciences · 2017Review
- Beyond the hype: deep neural networks outperform established methods using a ChEMBL bioactivity benchmark set.Journal of cheminformatics · 2017Article
- The polypharmacology browser: a web-based multi-fingerprint target prediction tool using ChEMBL bioactivity data.Journal of cheminformatics · 2017Article
- Combination therapeutics in complex diseases.Journal of cellular and molecular medicine · 2016Review
- Open PHACTS computational protocols forMedChemComm · 2016Article
- DRABAL: novel method to mine large high-throughput screening assays using Bayesian active learning.Journal of cheminformatics · 2016Article
- Improving chemical similarity ensemble approach in target prediction.Journal of cheminformatics · 2016Article
- Selectivity profiling of BCRP versus P-gp inhibition: from automated collection of polypharmacology data to multi-label learning.Journal of cheminformatics · 2016Article
- A note on utilising binary features as ligand descriptors.Journal of cheminformatics · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAccording to Cobanoglu et al., it is now widely acknowledged that the single target paradigm (one protein/target, one disease, one drug) that has been the dominant premise in drug development in the recent past is untenable. More often than not, a drug-like compound (ligand) can be promiscuous - it can interact with more than one target protein. In recent years, in in silico target prediction methods the promiscuity issue has generally been approached computationally in three main ways: ligand-based methods; target-protein-based methods; and integrative schemes. In this study we confine attention to ligand-based target prediction machine learning approaches, commonly referred to as target-fishing. The target-fishing approaches that are currently ubiquitous in cheminformatics literature can be essentially viewed as single-label multi-classification schemes; these approaches inherently bank on the single target paradigm assumption that a ligand can zero in on one single target. In order to address the ligand promiscuity issue, one might be able to cast target-fishing as a multi-label multi-class classification problem. For illustrative and comparison purposes, single-label and multi-label Naïve Bayes classification models (denoted here by SMM and MMM, respectively) for target-fishing were implemented. The models were constructed and tested on 65,587 compounds/ligands and 308 targets retrieved from the ChEMBL17 database.
resultsOn classifying 3,332 test multi-label (promiscuous) compounds, SMM and MMM performed differently. At the 0.05 significance level, a Wilcoxon signed rank test performed on the paired target predictions yielded by SMM and MMM for the test ligands gave a p-value < 5.1 × 10(-94) and test statistics value of 6.8 × 10(5), in favour of MMM. The two models performed differently when tested on four datasets comprising single-label (non-promiscuous) compounds; McNemar's test yielded χ (2) values of 15.657, 16.500 and 16.405 (with corresponding p-values of 7.594 × 10(-05), 4.865 × 10(-05) and 5.115 × 10(-05)), respectively, for three test sets, in favour of MMM. The models performed similarly on the fourth set.
conclusionsThe target prediction results obtained in this study indicate that multi-label multi-class approaches are more apt than the ubiquitous single-label multi-class schemes when it comes to the application of ligand-based classifiers to target-fishing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.